CLINICA CAYANGA |
||
|
|
Doxycycline does not improve acute sinusitis |
|
|
Alzheimer's
Disease Arthritis Asthma Benign Prostatic Hypertrophy Chronic Lymphocytic Leukemia Coronary Artery Disease Depression Diabetes Mellitus Dyspepsia Erectile Dysfunction Fatty Liver Gallstone Hepatitis Hypertension Lung Cancer Mesothelioma Metabolic Syndrome Obesity Pneumonia Pregnancy Prostate Cancer Sinusitis Stroke Tinnitus |
Clinical Question: Does doxycycline work better than placebo in resolving symptoms of sinusitis in adults? Bottom Line: The addition of doxycycline adds no important benefit over the use of topical nasal decongestants. This is consistent with recent recommendations from the CDC that no antibiotics be used in the treatment of acute sinusitis unless the patient is symptomatic for over 14 days or if the infection is severe. (LOE = 1b) Reference: Stalman W, van Essen GA, van der Graaf Y, de Melker RA. The end of antibiotic treatment in adults with acute sinusitis−like complaints in general practice? A placebo−controlled double−blind randomized doxycycline trial. Br J Gen Pract 1997;47:794−9. Study Design: Randomized controlled trial (double−blinded) Synopsis: Acute sinusitis-like complaints are very common and are usually treated with antibiotics in spite of the lack of evidence for the effectiveness of antibiotic therapy and the increasing number of resistant strains. The authors assessed the effectiveness of doxycycline in adults with acute sinusitis-like complaints in general practice. The effects of doxycycline in a placebo-controlled, double-blind, randomized trial were assessed in adults consulting their general practitioner (GP) with complaints after a common cold or influenza, pain in the head when bending forward, purulent nasal discharge, predominantly unilateral maxillary pain, toothache, or pain when chewing. Primary outcome events were the resolution of facial pain and the resumption of daily activities. Treatment differences were assessed by means of Kaplan-Meier curves and hazard ratios. The follow-up period was 42 days. No significant difference was found in time to recover between the doxycycline-treated group and the placebo-treated group. However, the adjusted hazard ratio for the group receiving doxycycline was 1.17 (95% CI = 0.87-1.57) for the resolution of pain and 1.31 (95% CI = 0.96-1.78) for the resumption of daily activities. After 10 days, 85% of all patients reported improvement and 60% were completely cured. Side effects were reported by 17% of the doxycycline-treated group, with two patients withdrawing because of side effects..
|
|
|
Patient Information |
||
| Health For Life | ||
|
Medical Library |
||
|
Breaking Medical News Clinical Tools Coronary Risk Profile Dermatology Diabetes Corner Evidence-Based Medicine Free Medical Books Free Medical Journal History Taking and Physical Examination Hows on Making Diagnostic Examination Medical Journal (popular) Medical Organizations Medical Professional News Neurological and Psychiatric Problems in Clinical Practice Palm Tools Medical Notes Medical Physiology (Lecture) Medical Resources Medical Search Online Clinical Calculator Scientific Meeting |
||
| Online Sari-Sari Store | ||
Please
support Clinica Cayanga Medical Resources by purchasing gift items
at  |
||
|
Home | Introduction | Scheduling a Visit| Laboratory Work | Reaching Us | Map to our Office | About the Doctors |
||